These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 16723080)
21. Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells. Thangasamy A; Rogge J; Ammanamanchi S J Biol Chem; 2008 Feb; 283(9):5335-43. PubMed ID: 18165235 [TBL] [Abstract][Full Text] [Related]
22. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression. Kretschmann KL; Eyob H; Buys SS; Welm AL Curr Drug Targets; 2010 Sep; 11(9):1157-68. PubMed ID: 20545605 [TBL] [Abstract][Full Text] [Related]
23. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein. Ma Q; Guin S; Padhye SS; Zhou YQ; Zhang RW; Wang MH Mol Cancer; 2011 May; 10():66. PubMed ID: 21619683 [TBL] [Abstract][Full Text] [Related]
24. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells. Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262 [TBL] [Abstract][Full Text] [Related]
25. Ron-receptor tyrosine kinase in tumorigenesis and metastasis. Leonis MA; Thobe MN; Waltz SE Future Oncol; 2007 Aug; 3(4):441-8. PubMed ID: 17661719 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase. Koh XY; Koh XH; Hwang LA; Ferrer FJ; Rahmat SAB; Lama D; Lane DP Oncogene; 2019 Nov; 38(48):7342-7356. PubMed ID: 31417186 [TBL] [Abstract][Full Text] [Related]
27. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma. Vanderwerff BR; Church KJ; Kawas LH; Harding JW Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. O'Toole JM; Rabenau KE; Burns K; Lu D; Mangalampalli V; Balderes P; Covino N; Bassi R; Prewett M; Gottfredsen KJ; Thobe MN; Cheng Y; Li Y; Hicklin DJ; Zhu Z; Waltz SE; Hayman MJ; Ludwig DL; Pereira DS Cancer Res; 2006 Sep; 66(18):9162-70. PubMed ID: 16982759 [TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cells. Park JS; Park JH; Lee S; Joo YE; Jung YD Oncol Rep; 2010 Sep; 24(3):709-14. PubMed ID: 20664977 [TBL] [Abstract][Full Text] [Related]
30. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells. Narasimhan M; Ammanamanchi S Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918 [TBL] [Abstract][Full Text] [Related]
31. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Wagh PK; Peace BE; Waltz SE Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091 [TBL] [Abstract][Full Text] [Related]
32. Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility. Zhang K; Yao HP; Wang MH Carcinogenesis; 2008 Mar; 29(3):552-9. PubMed ID: 18204077 [TBL] [Abstract][Full Text] [Related]
33. Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Recepteur d'origine nantais. Chen YQ; Zhou YQ; Fu LH; Wang D; Wang MH Carcinogenesis; 2002 Nov; 23(11):1811-9. PubMed ID: 12419829 [TBL] [Abstract][Full Text] [Related]
34. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells. Zhang K; Zhou YQ; Yao HP; Wang MH Int J Oncol; 2010 Jan; 36(1):255-64. PubMed ID: 19956854 [TBL] [Abstract][Full Text] [Related]
36. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Wang MH; Zhou YQ; Chen YQ Scand J Immunol; 2002 Dec; 56(6):545-53. PubMed ID: 12472665 [TBL] [Abstract][Full Text] [Related]
37. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. Benight NM; Wagh PK; Zinser GM; Peace BE; Stuart WD; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE Oncotarget; 2015 Jul; 6(19):17445-61. PubMed ID: 25938541 [TBL] [Abstract][Full Text] [Related]
38. Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration. Willett CG; Wang MH; Emanuel RL; Graham SA; Smith DI; Shridhar V; Sugarbaker DJ; Sunday ME Am J Respir Cell Mol Biol; 1998 Apr; 18(4):489-96. PubMed ID: 9533936 [TBL] [Abstract][Full Text] [Related]
39. Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells. Yu Q; Wang J; Li T; Guo X; Ding S; Che X; Zhu L; Peng Y; Xu X; Zou G; Zhang X J Cell Mol Med; 2021 Feb; 25(3):1601-1612. PubMed ID: 33410267 [TBL] [Abstract][Full Text] [Related]
40. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells. Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]